Advertisement

Malaria in Pregnancy and the Newborn

  • Stephen J. Rogerson
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 659)

Abstract

Each year, 40% of the world’s population is exposed to the risk of malaria infection. Approximately 500 million people suffer clinical disease episodes of malaria, and around one million die from it. The greater part of the world’s malaria burden falls on Africa, but recent analyses suggest the amount of malaria in Asia has been underestimated (Snow et al., 2005). Five Plasmodium species infect humans: P. falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi. The last, which is a common parasite of monkeys, has only recently been described as a human pathogen (Singh et al., ), but appears to be quite widespread in South East Asia. The great majority of severe disease episodes and deaths are due to P. falciparum, but it is becoming increasingly clear that P. vivax can also cause severe disease episodes and deaths (Genton et al., ; Tjitra et al., ). The main presentations of severe and life-threatening malaria are severe anaemia, cerebral malaria (unrouseable coma associated with malaria infection) and respiratory distress.

Keywords

Malaria Infection Cerebral Malaria Fetal Growth Restriction Parasite Prevalence Infected Erythrocyte 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

Stephen Rogerson is supported by the National Health and Medical Research Council of Australia and the Malaria in Pregnancy Consortium.

References

  1. Bardaji, A., Sigauque, B., Bruni, L., Romagosa, C., Sanz, S., Mabunda, S., Mandomando, I., Aponte, J., Sevene, E., Alonso, P.L., & Menendez, C. (2008). Clinical malaria in African pregnant women. Malar J, (7), 27.PubMedCrossRefGoogle Scholar
  2. Barker, D.J. (2006). Adult consequences of fetal growth restriction. Clinical Obstetrics and Gynecology, (49), 270–283.PubMedCrossRefGoogle Scholar
  3. Beeson, J.G., Brown, G.V., Molyneux, M.E., Mhango, C., Dzinjalamala, F., & Rogerson, S.J. (1999). Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J Infect Dis, (180), 464–472.PubMedCrossRefGoogle Scholar
  4. Brabin, B.J. (1983). An analysis of malaria in pregnancy in Africa. Bull WHO, (61), 1005–1016.PubMedGoogle Scholar
  5. Brabin, B.J., Agbaje, S.O., Ahmed, Y., & Briggs, N.D. (1999). A birthweight nomogram for Africa, as a malaria-control indicator. Ann Trop Med Parasitol, 93 (Suppl 1), S43–S57.PubMedGoogle Scholar
  6. Brabin, B.J. & Rogerson, S.J. (2001). The epidemiology and outcomes of maternal malaria. In: P.E. Duffy, M. Fried (Eds.) Malaria in Pregnancy Deadly Parasite, Susceptible Host. pp. 27–52. London and New York: Taylor and Francis.CrossRefGoogle Scholar
  7. Brabin, L. (2004). The adolescent health gap in developing countries. Ann Trop Paediatr, (24), 115–116.PubMedCrossRefGoogle Scholar
  8. Clark, R.L., White, T.E., S, A.C., Gaunt, I., Winstanley, P., & Ward, S.A. (2004). Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res B Dev Reprod Toxicol, (71), 380–394.PubMedCrossRefGoogle Scholar
  9. Coulibaly, S.O., Gies, S., & D’Alessandro, U. (2007). Malaria burden among pregnant women living in the rural district of Boromo, Burkina Faso. Am J Trop Med Hyg, (77), 56–60.PubMedGoogle Scholar
  10. Desai, M., ter Kuile, F.O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R.D. (2007). Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis, (7), 93–104.PubMedCrossRefGoogle Scholar
  11. Dondorp, A., Nosten, F., Stepniewska, K., Day, N., & White, N. (2005). Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet, (366), 717–725.PubMedCrossRefGoogle Scholar
  12. Duffy, M.F., Byrne, T.J., Elliott, S.R., Wilson, D., Rogerson, S.J., Beeson, J.G., Noviyanti, R., & Brown, G.V. (2005). Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype. Mol Microbiol, (56), 774–788.PubMedCrossRefGoogle Scholar
  13. Duffy, M.F., Caragounis, A., Noviyanti, R., Kyriacou, H.M., Choong, E.K., Boysen, K., Healer, J., Rowe, J.A., Molyneux, M.E., Brown, G.V., & Rogerson, S.J. (2006a). Transcribed var genes associated with placental malaria in Malawian women. Infect Immun, 74(8), 4875–4883.PubMedCrossRefGoogle Scholar
  14. Duffy, M.F., Maier, A.G., Byrne, T.J., Marty, A.J., Elliott, S.R., O’Neill, M.T., Payne, P.D., Rogerson, S.J., Cowman, A.F., Crabb, B.S., & Brown, G.V. (2006b). VAR2SCA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. Mol Biochem Parasitol, (148), 117–124.PubMedCrossRefGoogle Scholar
  15. Duffy, P.E. & Fried, M. (2003). Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun, (71), 6620–6623.PubMedCrossRefGoogle Scholar
  16. Fischer, P.R. (2003). Malaria and newborns. J Trop Pediatr, (49), 132–134.PubMedCrossRefGoogle Scholar
  17. Francis, S.E., Malkov, V.A., Oleinikov, A.V., Rossnagle, E., Wendler, J.P., Mutabingwa, T.K., Fried, M., & Duffy, P.E. (2007). Six genes are preferentially transcribed by the circulating and sequestered forms of Plasmodium falciparum parasites that infect pregnant women. Infect Immun, (75), 4838–4850.PubMedCrossRefGoogle Scholar
  18. Fried, M., Domingo, G.J., Gowda, C.D., Mutabingwa, T.K., & Duffy, P.E. (2006). Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta. Exp Parasitol, 113(1), 36–42.PubMedCrossRefGoogle Scholar
  19. Fried, M. & Duffy, P.E. (1996). Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science, (272), 1502–1504.PubMedCrossRefGoogle Scholar
  20. Fried, M., Muga, R.O., Misore, A.O., & Duffy, P.E. (1998). Malaria elicits type 1 cytokines in the human placenta: IFN-γ and TNF-α associated with pregnancy outcomes. J Immunol, (160), 2523–2530.PubMedGoogle Scholar
  21. Garner, P., & Gulmezoglu, A.M. (2006). Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev, CD000169.Google Scholar
  22. Genton, B., D’Acremont, V., Rare, L., Baea, K., Reeder, J.C., Alpers, M.P., & Mueller, I.M. (2008). Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med, (5), e127.PubMedCrossRefGoogle Scholar
  23. Green, M.D., van Eijk, A.M., van Ter Kuile, F.O., Ayisi, J.G., Parise, M.E., Kager, P.A., Nahlen, B.L., Steketee, R., & Nettey, H. (2007). Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya. J Infect Dis, (196), 1403–1408.PubMedCrossRefGoogle Scholar
  24. Guyatt, H.L. & Snow, R.W. (2001). The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. Am J Trop Med Hyg, 64 (Suppl), 36–44.PubMedGoogle Scholar
  25. Guyatt, H.L. & Snow, R.W. (2004). Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev, (17), 760–769, table of contents.PubMedCrossRefGoogle Scholar
  26. Haase, R.N., Megnekou, R., Lundquist, M., Ofori, M.F., Hviid, L., & Staalsoe, T. (2006). Plasmodium falciparum parasites expressing pregnancy-specific variant surface antigens adhere strongly to the choriocarcinoma cell line BeWo. Infect Immun, (74), 3035–3038.PubMedCrossRefGoogle Scholar
  27. Hart, C.A. (1988). Pregnancy and host resistance. Baillieres Clin Immunol Allergy, (2), 735–757.Google Scholar
  28. Hviid, L. (2004). The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective. Parasite Immunol, (26), 477–486.PubMedCrossRefGoogle Scholar
  29. Hviid, L. & Staalsoe, T. (2004). Malaria immunity in infants: a special case of a general phenomenon? Trends Parasitol, (20), 66–72.PubMedCrossRefGoogle Scholar
  30. Le Hesran, J.Y., Cot, M., Personne, P., Fievet, N., Dubois, B., Beyeme, M., Boudin, C., & Deloron, P. (1997). Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Epidemiol, (146), 826–831.PubMedGoogle Scholar
  31. Lesko, C.R., Arguin, P.M., & Newman, R.D. (2007). Congenital malaria in the United States: a review of cases from 1966 to 2005. Arch Pediatr Adolesc Med, (161), 1062–1067.PubMedCrossRefGoogle Scholar
  32. Lindsay, S., Ansell, J., Selman, C., Cox, V., Hamilton, K., & Walraven, G. (2000). Effect of pregnancy on exposure to malaria mosquitoes. Lancet, (355), 1972.PubMedCrossRefGoogle Scholar
  33. Lucchi, N.W., Koopman, R., Peterson, D.S., & Moore, J.M. (2006). Plasmodium falciparum-infected red blood cells selected for binding to cultured syncytiotrophoblast bind to chondroitin sulfate A and induce tyrosine phosphorylation in the syncytiotrophoblast. Placenta, (27), 384–394.PubMedCrossRefGoogle Scholar
  34. Malhotra, I., Mungai, P., Muchiri, E., Kwiek, J.J., Meshnick, S.R., & King, C.L. (2006). Umbilical cord-blood infections with Plasmodium falciparum malaria are acquired antenatally in kenya. J Infect Dis, (194), 176–183.PubMedCrossRefGoogle Scholar
  35. Marsh, K. & Kinyanjui, S. (2006). Immune effector mechanisms in malaria. Parasite Immunol, (28), 51–60.PubMedCrossRefGoogle Scholar
  36. Maubert, B., Fievet, N., Tami, G., Cot, M., Boudin, C., & Deloron, P. (1999). Development of antibodies against chondroitin sulfate A-adherent Plasmodium falciparum in pregnant women. Infect Immun, (67), 5367–5371.PubMedGoogle Scholar
  37. Menendez, C. & Mayor, A. (2007). Congenital malaria: the least known consequence of malaria in pregnancy. Semin Fetal Neonatal Med, (12), 207–213.PubMedCrossRefGoogle Scholar
  38. Menendez, C., Ordi, J., Ismail, M.R., Ventura, P.J., Aponte, J.J., Kahigwa, E., Font, F., & Alonso, P.L. (2000). The impact of placental malaria on gestational age and birth weight. J Infect Dis, (181), 1740–1745.PubMedCrossRefGoogle Scholar
  39. Moormann, A.M., Sullivan, A.D., Rochford, R.A., Chensue, S.W., Bock, P.J., Nyirenda, T., & Meshnick, S.R. (1999). Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J Infect Dis, (180), 1987–1993.PubMedCrossRefGoogle Scholar
  40. Mutabingwa, T.K., Bolla, M.C., Li, J.L., Domingo, G.J., Li, X., Fried, M., & Duffy, P.E. (2005). Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med, (2), e407.PubMedCrossRefGoogle Scholar
  41. Nosten, F., McGready, R., Simpson, J.A., Thwai, K.L., Balkan, S., Cho, T., Hkirijaroen, L., Looareesuwan, S., & White, N.J. (1999). Effects of Plasmodium vivax malaria in pregnancy. Lancet, (354), 546–549.PubMedCrossRefGoogle Scholar
  42. Parise, M.E., Ayisi, J.G., Nahlen, B.L., Schultz, L.J., Roberts, J.M., Misore, A., Muga, R., Oloo, A.J., & Steketee, R.W. (1998). Efficacy of sufadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg, (59), 813–822.PubMedGoogle Scholar
  43. Phillips-Howard, P.A. & Wood, D. (1996). The safety of antimalarial drugs in pregnancy. Drug Saf, (14), 131–145.PubMedCrossRefGoogle Scholar
  44. Poespoprodjo, J.R., Fobia, W., Kenangalem, E., Lampah, D.A., Warikar, N., Seal, A., McGready, R., Sugiarto, P., Tjitra, E., Anstey, N.M., & Price, R.N. (2008). Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis, (46), 1374–1381.PubMedCrossRefGoogle Scholar
  45. Riley, E.M., Wagner, G.E., Akanmori, B.D., & Koram, K.A. (2001). Do maternally acquired antibodies protect infants from malaria infection? Parasite Immunol, (23), 51–59.PubMedCrossRefGoogle Scholar
  46. Rogerson, S.J., Brown, H.C., Pollina, E., Abrams, E.T., Tadesse, E., Lema, V.M., & Molyneux, M.E. (2003a). Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women. Infect Immun, (71), 267–270.PubMedCrossRefGoogle Scholar
  47. Rogerson, S.J., Chaiyaroj, S.C., Ng, K., Reeder, J.C., & Brown, G.V. (1995). Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J Exp Med, (182), 15–20.PubMedCrossRefGoogle Scholar
  48. Rogerson, S.J., Chaluluka, E., Kanjala, M., Mkundika, P., Mhango, C.G., & Molyneux, M.E. (2000). Intermittent sulphadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi 1997–1999. Trans R Soc Trop Med Hyg, (94), 549–553.PubMedCrossRefGoogle Scholar
  49. Rogerson, S.J., Hviid, L., Duffy, P.E., Leke, R.F., & Taylor, D.W. (2007). Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis, (7), 105–117.PubMedCrossRefGoogle Scholar
  50. Rogerson, S.J. & Menendez, C. (2006). Treatment and prevention of malaria in pregnancy: opportunities and challenges. Expert Rev Anti Infect Ther, (4), 687–702.PubMedCrossRefGoogle Scholar
  51. Rogerson, S.J., Pollina, E., Getachew, A., Tadesse, E., Lema, V.M., & Molyneux, M.E. (2003b). Placental monocyte infiltrates in response to Plasmodium falciparum infection and their association with adverse pregnancy outcomes. Am J Trop Med Hyg, (68), 115–119.PubMedGoogle Scholar
  52. Salanti, A., Dahlback, M., Turner, L., Nielsen, M.A., Barfod, L., Magistrado, P., Jensen, A.T., Lavstsen, T., Ofori, M.F., Marsh, K., Hviid, L., & Theander, T.G. (2004). Evidence for the Involvement of VAR2SCA in pregnancy-associated Malaria. J Exp Med, (200), 1197–1203.PubMedCrossRefGoogle Scholar
  53. Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A.T., Sowa, M.P., Arnot, D.E., Hviid, L., & Theander, T.G. (2003). Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol, (49), 179–191.PubMedCrossRefGoogle Scholar
  54. Saute, F., Menendez, C., Mayor, A., Aponte, J., Gomez-Olive, X., Dgedge, M., & Alonso, P. (2002). Malaria in pregnancy in rural Mozambique: the role of parity, submicroscopic and multiple Plasmodium falciparum infections. Trop Med Int Health, (7), 19–28.PubMedCrossRefGoogle Scholar
  55. Singh, B., Kim Sung, L., Matusop, A., Radhakrishnan, A., Shamsul, S.S., Cox-Singh, J., Thomas, A., & Conway, D.J. (2004). A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet, (363), 1017–1024.PubMedCrossRefGoogle Scholar
  56. Singh, N., Shukla, M.M., & Sharma, V.P. (1999). Epidemiology of malaria in pregnancy in central India. Bull WHO, (77), 567–572.PubMedGoogle Scholar
  57. Snow, R.W., Guerra, C.A., Noor, A.M., Myint, H.Y., & Hay, S.I. (2005). The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature, (434), 214–217.PubMedCrossRefGoogle Scholar
  58. Staalsoe, T., Shulman, C.E., Bulmer, J.N., Kawuondo, K., Marsh, K., & Hviid, L. (2004). Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet, (363), 283–289.PubMedCrossRefGoogle Scholar
  59. Steketee, R.W., Nahlen, B.L., Parise, M.E., & Menendez, C. (2001). The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg, (64), 28–35.PubMedGoogle Scholar
  60. Suguitan, A.L., Jr., Leke, R.G., Fouda, G., Zhou, A., Thuita, L., Metenou, S., Fogako, J., Megnekou, R., & Taylor, D.W. (2003). Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. J Infect Dis, (188), 1074–1082.PubMedCrossRefGoogle Scholar
  61. Tagbor, H., Bruce, J., Browne, E., Greenwood, B., & Chandramohan, D. (2008). Malaria in pregnancy in an area of stable and intense transmission: is it asymptomatic? Trop Med Int Health, 13(8), 1016-1021.PubMedCrossRefGoogle Scholar
  62. ter Kuile, F.O., van Eijk, A.M., & Filler, S.J. (2007). Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. Jama, (297), 2603–2616.PubMedCrossRefGoogle Scholar
  63. Tjitra, E., Anstey, N.M., Sugiarto, P., Warikar, N., Kenangalem, E., Karyana, M., Lampah, D.A., & Price, R.N. (2008). Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia. PLoS Med, (5), e128.PubMedCrossRefGoogle Scholar
  64. Tobian, A.A.R., Mehlotra, R.K., Malhotra, I., Wamachi, A., Mungai, P., Koech, D., Ouma, J., Zimmerman, P., & King, C.L. (2000). Frequent umbilical cord-blood and maternal-blood infections with Plasmodium falciparum, P. malariae and P. ovale in Kenya. J Infect Dis, (182), 558–563.PubMedCrossRefGoogle Scholar
  65. Tuikue Ndam, N., Bischoff, E., Proux, C., Lavstsen, T., Salanti, A., Guitard, J., Nielsen, M.A., Coppee, J.Y., Gaye, A., Theander, T., David, P.H., & Deloron, P. (2008). Plasmodium falciparum transcriptome analysis reveals pregnancy malaria associated gene expression. PLoS ONE, (3), e1855.PubMedCrossRefGoogle Scholar
  66. Tuikue Ndam, N.G., Salanti, A., Bertin, G., Dahlback, M., Fievet, N., Turner, L., Gaye, A., Theander, T., & Deloron, P. (2005). High level of var2sca transcription by Plasmodium falciparum isolated from the placenta. J Infect Dis, (192), 331–335.PubMedCrossRefGoogle Scholar
  67. Viebig, N.K., Gamain, B., Scheidig, C., Lepolard, C., Przyborski, J., Lanzer, M., Gysin, J., & Scherf, A. (2005). A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep, (6), 775–781.PubMedCrossRefGoogle Scholar
  68. Vleugels, M.P.H., Brabin, B., Eling, W.M.C., & de Graaf, R. (1989). Cortisol and Plasmodium falciparum infection in pregnant women in Kenya. Trans R Soc Trop Med Hyg, (83), 173–177.PubMedCrossRefGoogle Scholar
  69. Walter, P.R., Garin, Y., & Blot, P. (1982). Placental pathologic changes in malaria. A histologic and ultrastructural study. Am J Pathol, (109), 330–342.PubMedGoogle Scholar
  70. Ward, S.A., Sevene, E.J., Hastings, I.M., Nosten, F., & McGready, R. (2007). Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect Dis, (7), 136–144.PubMedCrossRefGoogle Scholar
  71. Yosaatmadja, F., Andrews, K.T., Duffy, M.F., Brown, G.V., Beeson, J.G., & Rogerson, S.J. (2008). Characterization of VAR2SCA-deficient Plasmodium falciparum-infected erythrocytes selected for adhesion to the BeWo placental cell line. Malar J, (7), 51.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Medicine (RMH/WH)Post Office Royal Melbourne HospitalParkvilleAustralia

Personalised recommendations